CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
CASI Pharmaceuticals's total debt was $19.19M at Dec 31, 2025. For fiscal 2025 it was $19.19M, up 4.4% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.19M | +4.4% |
| FY2024 | Dec 31, 2024 | $18.39M | -2.7% |
| FY2023 | Dec 31, 2023 | $18.90M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $19.19M | – |
| Q4 FY2024 | Dec 31, 2024 | $18.39M | – |
| Q4 FY2023 | Dec 31, 2023 | $18.90M | – |
See a number that looks wrong?